Related Experiment Video
Updated: Dec 28, 2025
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.6K
The Need for Innovative Methods to Increase Adherence in Individuals Experiencing Cognitive Decline
Stacey L Gorniak1, Craig A Johnson1
1Department of Health and Human Performance, University of Houston, Houston, Texas.
American Journal of Lifestyle Medicine
|February 18, 2020
Summary
Addressing cognitive impairment in older adults is crucial. Innovative strategies are needed to improve adherence and promote healthy lifestyles, respecting patient autonomy.
Area of Science:
- Gerontology
- Neuroscience
- Public Health
Background:
- Cognitive impairment, especially in aging populations, presents significant challenges for healthcare providers and families.
- Nonadherence to treatment and lifestyle recommendations is a prevalent issue among individuals with cognitive impairment.
- This nonadherence raises concerns about respecting patient autonomy and ensuring effective healthcare management.
Purpose of the Study:
- To highlight the growing concern of cognitive impairment in the elderly.
- To emphasize the problem of nonadherence in this demographic.
- To underscore the necessity for innovative strategies to enhance adherence and promote healthy behaviors.
Main Methods:
- Literature review on cognitive impairment and adherence challenges.
- Analysis of factors contributing to nonadherence in older adults.
- Exploration of potential innovative strategies for improving adherence.
Main Results:
- Cognitive impairment significantly impacts adherence to health recommendations.
- Patient autonomy is a key ethical consideration in managing nonadherence.
- Innovative approaches are essential for successful intervention.
Conclusions:
- Effective management of cognitive impairment requires addressing adherence issues.
- Developing novel strategies is vital for improving health outcomes in older adults with cognitive impairment.
- Balancing patient autonomy with necessary interventions is critical for successful care.
More Related Videos
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.5K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.8K
Related Concept Videos
01:30Cognitive Development During Adulthood
701
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
701
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
456
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
456
01:22Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699
01:28Drug Therapy
204
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
204
01:26Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
01:30Dementia
458
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
458